Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021)
Most medications with potential teratogenic effects dispensed to women of childbearing age and pregnant women were in the group of weak teratogenicity level, and many women discontinued treatment before pregnancy. Preliminary evidence suggests the valproate pregnancy prevention program in Switzerland may be beneficial.
Authors
- Daniel Surbek (ORCID: https://orcid.org/0000-0001-7705-1584)
- Sereina M. Graber
- Julia Spoendlin (ORCID: https://orcid.org/0000-0003-1632-1928)
- Christoph Meier (ORCID: https://orcid.org/0000-0002-7120-6378)
- Alice Panchaud (ORCID: https://orcid.org/0000-0001-6086-2401)
- Carole A. Marxer (ORCID: https://orcid.org/0000-0002-4688-8223)
Institutions
- University of Bern (CH)
- University of Basel (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- Helsana Group (Switzerland) (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Acta Obstetricia Et Gynecologica Scandinavica
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1111/aogs.15052
- Citations
- 2
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Freiwillige Akademische Gesellschaft
- Universität zu Köln
- Universitätsklinikum Köln